The combination therapy in arterial hypertension: opportunities of the fixed combination of irbesartan andhydrochlorothiazide(Koaprovel’) | Zendy

О. Д. Остроумова | Zendy; T F Guseva | Zendy; О В Бондарец | Zendy

Open Access

The combination therapy in arterial hypertension: opportunities of the fixed combination of irbesartan andhydrochlorothiazide(Koaprovel’)

Author(s) -

О. Д. Остроумова,

T F Guseva,

О В Бондарец

Publication year - 2014

Publication title -

systemic hypertension

Language(s) - English

Resource type - Journals

eISSN - 2542-2189

pISSN - 2075-082X

DOI - 10.26442/sg29041

Subject(s) - irbesartan , hydrochlorothiazide , combination therapy , medicine , fixed dose combination , cardiology , pharmacology , blood pressure

The article deals with the various aspects of the combinationtherapyin arterial hypertension. We showed the complementary effects and benefits of the combination of angiotensin II receptor antagonistsand diuretics; also we described clinical caseswhere thiscombination therapy is forpriority use. In detail we analysed the literature data on the efficacy and safety of combination of irbesartan and hydrochlorothiazide, including long-term use.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research